4-Pro-MET vs 4-HO-MET
Prodrug vs Original – Onset, Duration, Stability & Effects Compared
4-Pro-MET er et prodrug af 4-HO-MET (metocin). I kroppen omdannes det enzymatisk til den samme aktive forbindelse. Men hvorfor overhovedet et prodrug, når originalet eksisterer? Kemi, stabilitet og farmakokinetik giver svaret. Denne sammenligning støtter sig på publicerede forskningsdata (Glatfelter et al. 2023), community-rapporter og kemiske grundprincipper. Du får at vide, hvor prodrug og original adskilles – og hvorfor denne sondring tæller for din forskning.
Indholdsfortegnelse
- Indlæser...
4-Pro-MET vs. 4-HO-MET: Direkte sammenligning
|
4-Pro-MET (Prodrug)
Empfohlen |
4-HO-MET (Metocin) | |
|---|---|---|
| Chemical Formula | C16H22N2O2 (MW 274.4) | C13H18N2O (MW 218.3) |
| Onset (oral) | 20-60 min (prodrug conversion) | 10-20 min (direct acting) |
| Duration | 5-8 hours | 4-6 hours |
| Storage Stability | Excellent (ester-protected) | Poor (oxidation-prone) |
| Legal Status (DE, 2026) | Not scheduled (BtMG/NpSG) | NpSG-covered since July 2019 |
Kernen: 4-Pro-MET bærer en propionyloxy-beskyttelsesgruppe i position 4 af indolringen. 4-HO-MET har dér en fri hydroxylgruppe. Denne beskyttelsesgruppe gør 4-Pro-MET til et prodrug – en forstadie, som esteraseenzymer i kroppen omdanner til den aktive form (4-HO-MET). Princippet kendes fra farmakologi: Psilocybin fungerer på samme måde som prodrug af psilocin.
Kemisk sammenligning
- 4-Pro-MET: C15H20N2O2 – molekylvægt 274,4 g/mol – propionyloxy-ester i position 4
- 4-HO-MET: C13H18N2O – molekylvægt 218,3 g/mol – fri hydroxylgruppe i position 4
- Masseforskel: 56,1 g/mol (≈ 20% af prodrug-vægten tilhører beskyttelsesgruppen)
Begge deler det identiske tryptamin-grundskelet med N-methyl-N-ethyl-substitution på sidekæden. Alexander Shulgin syntetiserede 4-HO-MET første gang i 1970'erne – opgang #21 i TiHKAL (1997), anbefalet forskningsdosis 10–20 mg oralt. 4-Pro-MET? Det dukkede først op i august/september 2025 som nyt forskemikali. En aldersforskel på et halvt århundrede.
4-Pro-MET is a prodrug of 4-HO-MET. Esterase enzymes cleave the propionyloxy ester group in the body, releasing 4-HO-MET as the active metabolite and propanoic acid as a benign byproduct. Because both routes end at the same molecule acting on 5-HT2A and other serotonin receptors, the subjective effects are expected to be pharmacologically identical once conversion finishes.
The real difference is timing. 4-HO-MET acts directly, producing effects within 10-20 minutes. 4-Pro-MET needs enzymatic conversion first, pushing onset back by an additional 10-40 minutes. And that delay isn't just a number – community reports consistently call 4-Pro-MET's come-up "smoother" and "more gradual" compared to 4-HO-MET's rapid onset.
One thing worth knowing for dosing: approximately 20% of 4-Pro-MET's molecular weight is the propionyloxy group, which gets removed before activation. So 20 mg of 4-Pro-MET delivers roughly 16 mg equivalent of active 4-HO-MET.
Esterase-katalyseret hydrolyse – således hedder processen. Propionyloxy-gruppen spaltes, efterlader 4-HO-MET og propionsyre, en kortkædet fedtsyre, der naturligt forekommer i stofskiftet. Det samme princip ses ved andre tryptamin-prodrugs:
- Psilocybin – psilocin (phosphoryloxy-gruppen spaltes)
- 4-AcO-DMT – psilocin (acetyloxy-gruppen spaltes)
- 4-Pro-MET – 4-HO-MET (propionyloxy-gruppen spaltes)
Men vær opmærksom: Per april 2026 eksisterer der ingen publicerede in vivo-studier, der specifikt dokumenterer denne prodrug-omdannelse for 4-Pro-MET. Hypotesen støtter sig på tre søjler: strukturel analogi til 4-AcO-derivater, ligheden i de rapporterede effekter med 4-HO-MET i community-rapporter og den kendte esteraseaktivitet over for lignende estere. Om 4-Pro-MET selv – altså inden omdannelse – har relevant receptoraktivitet? Uklart. Data for det beslægtede 4-PrO-DMT (Glatfelter et al. 2023) tyder dog på en vis direkte receptorbinding.
This is where the gap gets dramatic. 4-HO-MET's free hydroxyl group at position 4 is highly susceptible to atmospheric oxidation, producing dark degradation products and potency loss within days to weeks under ambient conditions. Psilocin – the structural analogue with N,N-dimethyl substitution – has the same problem. It's why mushrooms bruise blue: oxidation of the 4-hydroxyl.
4-Pro-MET's propionyloxy ester caps that vulnerable position, delivering months to years of stability under basic storage conditions. And that stability edge is one of the main practical reasons 4-Pro-MET has gained market traction since appearing in 2025 – it's simply far easier to store and ship without degradation.
4-HO-MET har et stabilitetsproblem. Et alvorligt. Den frie hydroxylgruppe i position 4 er ekstremt oxidationsfølsom – i luft, lys og fugt nedbrydes stoffet hurtigt, misfarves mørkt og mister renhed. For analytisk forskning er det en dealbreaker: Nedbrudte prøver leverer ingen brugbare resultater.
Stabilitetssammenligning
- 4-HO-MET: Holdbarhed få uger til måneder ved stuetemperatur; kræver inertgas-overbrusning (N2/Ar), dybfrysning (-20 °C) og absolut tørhed til langtidsopbevaring
- 4-Pro-MET: Estimeret holdbarhed 2–3 år ved korrekt opbevaring (køligt, tørt, lysbeskyttet); propionyloxy-gruppen afskærmer sterisk den følsomme 4-position
Arrhenius-reglen gør det håndgribeligt: Enhver 10 °C temperaturstigning fordobler nedbrydningshastigheden. Ved stuetemperatur (22 °C) nedbrydes 4-HO-MET ca. 4 gange hurtigere end ved køleskabstemperatur (4 °C). 4-Pro-MET tåler stuetemperatur betydeligt bedre – en fordel, der i laboratorier uden dedikeret køl gør en forskel.
Yderligere prodrug-fordele
- Højere lipofilitet: Estimeret logP på 1,8–2,2 (vs. ~0,8–1,2 for 4-HO-MET) – bedre membranpermeabilitet
- Kontrolleret onset: Den enzymatiske omdannelse forsinker let virkningsindsættet, tilstrømningen forløber mere gradvist
- Retlig status: 4-HO-MET er i Danmark underlagt kontrol som nyt psykoaktivt stof; 4-Pro-MET er per april 2026 hverken oplistet på narkotikalisterne eller listen over nye psykoaktive stoffer
In Germany, 4-HO-MET has been covered by the NpSG since July 18, 2019. 4-Pro-MET, as of April 2026, isn't listed in the BtMG and falls outside the NpSG's structural definitions. So the prodrug is legal while the active metabolite is regulated – a legal asymmetry that shapes 4-Pro-MET's entire market position. But this status could change at any time through legislative action.
Juridisk meddelelse
Dies ist ein Beispiel-Infotext. Hier können Sie wichtige Hinweise für Ihre Leser hinterlegen.
Order 4-Pro-MET – Legal Alternative
Lab-tested – EU shipping – Not NpSG-scheduled
FAQ: 4-Pro-MET vs 4-HO-MET
4-Pro-MET is a prodrug that converts to 4-HO-MET in the body. The effects are believed to be pharmacologically identical once conversion is complete, but they differ in onset (20-60 vs 10-20 min), duration (5-8 vs 4-6 hrs), stability, and legal status.
4-HO-MET acts directly with onset in 10-20 minutes. 4-Pro-MET requires enzymatic conversion, delaying onset to 20-60 minutes. Community reports describe 4-Pro-MET's onset as smoother and more gradual.
In Germany as of April 2026: 4-HO-MET is covered by the NpSG (since July 2019), while 4-Pro-MET is not scheduled under either BtMG or NpSG. This legal asymmetry is a key factor in 4-Pro-MET's market position. Status may change.
Apply a ~20% mass correction: 4-Pro-MET's propionyloxy group adds weight that is removed before activation. 20 mg 4-Pro-MET delivers approximately 16 mg equivalent of active 4-HO-MET. This means 4-Pro-MET is slightly less potent per milligram.
4-Pro-MET is far more stable. Its propionyloxy ester protects against oxidation, allowing months to years of shelf life. 4-HO-MET's free hydroxyl group degrades rapidly – significant potency loss can occur within days to weeks under ambient conditions.
x
Please sign in to write a comment.